SCHEMBL21717016

SCHEMBL21717016

c1ccc2c(c1)ccc1ccc(-c3nc4ccccc4nc3-c3ccc(-n4c5ccccc5c5cc6ccc(-n7c8ccccc8c8ccc9ccccc9c87)cc6cc54)cc3)cc12

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.34
F10 P00742 1/20 0.34
PRSS1 P07477 1/20 0.34
KDM4E B2RXH2 1/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
HPGD P15428 1/20 0.31
PDPK1 O15530 2/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
MTOR P42345 1/20 0.31
MAPK8 P45983 1/20 0.30
MAPK9 P45984 1/20 0.30
MAPK10 P53779 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HIF1A Q16665 1/20 0.30
CYP1B1 Q16678 1/20 0.30
HSD17B10 Q99714 1/20 0.30
NPY5R Q15761 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716491 0.95 L3MBTL1 (0.36) F2F10PRSS1KDM4EATM
SCHEMBL21717226 0.94 KDM4E (0.35) F2F10PRSS1KDM4EATM
SCHEMBL21716440 0.94 L3MBTL1 (0.36) F2F10PRSS1KDM4EATM
SCHEMBL21716956 0.94 L3MBTL1 (0.36) F2F10PRSS1KDM4EATM
SCHEMBL21716485 0.93 F2 (0.32) F2F10PRSS1KDM4EATM
SCHEMBL21717654 0.92 MAPK8 (0.34) F2F10PRSS1KDM4EATM
SCHEMBL21717029 0.91 F2 (0.32) F2F10PRSS1HPGDPDPK1
SCHEMBL21716750 0.91 HPGD (0.30) HPGDPDPK1
SCHEMBL21716746 0.91 L3MBTL1 (0.35) F2F10PRSS1KDM4EATM
SCHEMBL21716498 0.91 HPGD (0.33) F2F10PRSS1HPGDPDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 F2 1187/4885F10 2054/4885PRSS1 4439/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 F2 1187/4885F10 2054/4885PRSS1 4439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.